PSN Urges Tinubu to Declare Pharmaceutical Insecurity a National Security Threat, Cites Drug Diversion, Terrorism Links - The Crown Online

Breaking

Thursday, November 5, 2026

PSN Urges Tinubu to Declare Pharmaceutical Insecurity a National Security Threat, Cites Drug Diversion, Terrorism Links

The Pharmaceutical Society of Nigeria (PSN) has called on President Bola Ahmed Tinubu to declare pharmaceutical insecurity a national security threat, warning that the diversion of controlled medicines and proliferation of unregulated drug markets are creating dangerous links between drug trafficking, banditry, terrorism and organised crime.

The Society also urged the Federal Government to replace open drug markets with licensed Coordinated Wholesale Centres (CWCs), insisting that the procurement, storage, distribution and dispensing of medicines, particularly controlled and psychoactive substances, must remain under effective government regulation and supervision.

The PSN President, Pharm. Ayuba Ibrahim Tanko, made the call in Awka, Anambra State, while delivering his presidential address at the opening of the Society's 99th Annual National Conference, tagged PSN-IJELE 2026, held at the International Convention Centre.

Tanko expressed concern over what he described as the growing threat of pharmaceutical insecurity, stressing that medicines should not be treated as ordinary commercial commodities because of their significant public health, regulatory and national security implications.

"Drugs are a matter of permanent regulatory control and national security," he declared.

He maintained that the Federal Government must not surrender the country's pharmaceutical supply chain to private commercial interests, arguing that effective government oversight was essential to ensuring accountability, regulatory compliance and national security.

PSN Raises Concerns Over Medipool Initiative

The Society's position comes amid ongoing discussions surrounding the Federal Government's Medipool initiative, approved by the Federal Executive Council in May 2025 as a National Group Purchasing Organisation (GPO).

Although the initiative is designed to reduce medicine prices, minimise stock-outs, promote transparent procurement and support local pharmaceutical manufacturers, the PSN expressed reservations about its structure, legal framework and proposed operational arrangements.

Tanko clarified that the Society was not opposed to pooled procurement but insisted that any implementation model must comply with existing laws and regulatory requirements.

"The GPO idea itself has support. The debate is about structure and legality, not about pooled purchasing as such," he said.

He questioned the proposed involvement of a private company in the supply chain of public health facilities, citing possible conflicts with the Public Procurement Act 2007, Pharmacy Council of Nigeria (PCN) Act 2022 and National Health Act 2014.

According to him, the constitutional placement of drugs and poisons on the Exclusive Legislative List underscores the importance of maintaining uniform national regulatory control over pharmaceutical products.

He warned that transferring significant aspects of the pharmaceutical value chain to a private concessionaire could weaken collaboration among government institutions, particularly the PCN, National Agency for Food and Drug Administration and Control (NAFDAC) and National Drug Law Enforcement Agency (NDLEA).

"Government cannot transfer its standing at the cooperation and goodwill that NAFDAC, the NDLEA and the PCN extend to Federal Health Institutions. The same latitude cannot be granted to a private concessionaire," he cautioned.

Drug Diversion, Tramadol Abuse and National Security

The PSN president further linked the diversion and abuse of controlled medicines, particularly tramadol and pentazocine, to Nigeria's security challenges.

Citing findings attributed to the NDLEA, Tanko identified the abuse of diverted controlled medicines as a significant concern in relation to banditry, terrorism and violent extremism.

He also referenced an estimated 14.3 million drug users in Nigeria, warning that weak pharmaceutical distribution controls could provide opportunities for illicit drug networks to flourish.

Among the incidents highlighted was the November 2025 arrest of a suspected supplier of tramadol, codeine syrup and other drugs to bandits operating across Kaduna, Katsina, Zamfara and Sokoto states.

He also cited the NDLEA's interception of 1.6 million tramadol pills in July 2026 during a cross-border trafficking operation reportedly destined for Kano.

Tanko argued that illicit pharmaceutical trade, money laundering and insecurity were interconnected, noting that poor traceability and unregulated distribution channels could facilitate smuggling and the financing of organised criminal activities.

He therefore advocated strict public oversight of medicines, especially controlled and psychoactive substances, throughout the procurement, storage, distribution and dispensing processes.

PSN Raises Alarm Over Fake and Substandard Medicines

Tanko also expressed concern over the influx of counterfeit and substandard medicines into the Nigerian market.

He cited NAFDAC's reported destruction of fake and substandard pharmaceutical products valued at approximately N1.5 trillion between June 2025 and June 2026.

According to him, the agency also secured 64 convictions within the period, while regulatory authorities sealed 3,027 shops, warehouses and stores during enforcement operations at Idumota, Lagos, in February 2025.

The PSN president said the scale of counterfeit drug trafficking required a more effective government-controlled distribution and monitoring system.

He equally questioned the adequacy of provisions in the Medipool arrangement regarding liability for counterfeit products supplied by third parties.

Tanko further raised concerns about the regulatory credentials of the company associated with the initiative, alleging that it was registered as a retail pharmacy rather than as a wholesaler or distributor with demonstrable experience in large-scale pharmaceutical distribution.

He called on the Federal Ministry of Health to conduct comprehensive regulatory due diligence and establish the company's compliance with the PCN Act before proceeding with any private-sector engagement.

Seven Recommendations to Strengthen Pharmaceutical Security

To address the challenges, the PSN outlined seven major recommendations for the Federal Government.

Among them is a call for President Tinubu to formally declare pharmaceutical insecurity a national security threat and replace open drug markets with licensed Coordinated Wholesale Centres.

The Society also proposed the integration of more than 10,000 community pharmacists into the national security architecture as frontline stakeholders who could identify suspicious pharmaceutical activities and provide early warning information to relevant authorities.

It further called for the expansion of the National Health Insurance Authority's Pharmacy First initiative, as proposed by the Association of Community Pharmacists of Nigeria.

Another recommendation is the establishment of a special fund against illicit financial flows in healthcare, to be financed through one per cent of assets recovered from drug trafficking activities. The proposed fund would support regulatory enforcement and rehabilitation programmes.

The PSN also urged the Federal Government to fast-track the Federal Drug Revolving Fund and Drug Management Agency Bill, which it said passed first reading at the House of Representatives in 2025.

According to the Society, the proposed agency should provide a legally protected central purchasing and supply platform for federal health institutions.

Under the proposed framework, Medipool could participate as a pooled price negotiator or framework supplier, provided its engagement was competitive and non-exclusive.

The Society further insisted that purchasing decisions, quality assurance, storage, dispensing and the management of controlled medicines should remain under government pharmacists working in collaboration with the PCN, NAFDAC and NDLEA.

It also proposed the establishment of a Presidential Committee on the Pharmaceutical Sector under the direct supervision of President Tinubu. The committee, according to the PSN, should be chaired by a registered pharmacist recommended by the Society, with representatives from the PCN, NAFDAC, National Institute for Pharmaceutical Research and Development (NIPRD) and the PSN.

PSN Commends NLC, TUC and JOHESU Over CONHESS Negotiations

In a separate development, the PSN commended the Nigeria Labour Congress (NLC), Trade Union Congress (TUC) and Joint Health Sector Unions (JOHESU) over progress recorded in negotiations with the Federal Government concerning the long-standing adjustment of the Consolidated Health Salary Structure (CONHESS).

Tanko disclosed that negotiations held on October 22 and 27, 2026, had produced important commitments towards resolving the prolonged dispute over the salary structure, which remained outstanding years after the adjustment of the Consolidated Medical Salary Structure (CONMESS).

He particularly acknowledged the contributions of two JOHESU representatives, including a pharmacist who served as the union's spokesperson, during the negotiations.

According to him, the discussions resulted in an agreement for the payment of 19 months' outstanding allowances owed to health workers, with the arrears scheduled to be paid in three instalments over three months, beginning in December 2026.

He also disclosed that the National Salaries, Incomes and Wages Commission (NSIWC) had undertaken to complete an updated assessment of the financial implications of the CONHESS adjustment within three weeks.

The updated assessment is expected to facilitate the necessary approvals by the Presidential Committee on Salaries for implementation.

Tanko explained that the review became necessary because changes in staffing levels across Federal Health Institutions might have affected the N49.6 billion projected cost contained in the Federal Government's 2022 Technical Committee report.

He also praised the TUC for insisting that the Federal Government honour its agreement with organised labour, a development that reportedly contributed to the suspension of an 84-day strike by health workers earlier in 2026.

The PSN president appealed to the NLC and TUC to ensure that the outstanding CONHESS adjustment was concluded with the necessary NSIWC circular and salary tables before the end of 2026.

He described the development as an important step towards addressing longstanding concerns over remuneration disparities among health professionals.

Conference to Focus on the Future of Pharmacy Practice

The 99th Annual National Conference, which has attracted pharmacists from different parts of the country, is expected to feature scientific sessions, town hall meetings, the Society's Annual General Meeting and other professional engagements.

Tanko expressed appreciation to the Anambra State Government for hosting the pharmaceutical community and providing an enabling environment for the conference.

He urged pharmacists to use the gathering to explore emerging opportunities, strengthen professional practice and contribute meaningfully to the development of Nigeria's healthcare system.

The PSN president added that the conference should provide an opportunity for critical conversations on the future of pharmacy practice and the strategic role of pharmacists in addressing Nigeria's healthcare delivery and pharmaceutical security challenges.

No comments:

Post a Comment